George Van Buren

4.8k total citations
52 papers, 2.2k citations indexed

About

George Van Buren is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, George Van Buren has authored 52 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 20 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in George Van Buren's work include Pancreatic and Hepatic Oncology Research (29 papers), Pancreatitis Pathology and Treatment (14 papers) and Renal cell carcinoma treatment (5 papers). George Van Buren is often cited by papers focused on Pancreatic and Hepatic Oncology Research (29 papers), Pancreatitis Pathology and Treatment (14 papers) and Renal cell carcinoma treatment (5 papers). George Van Buren collaborates with scholars based in United States, Germany and Canada. George Van Buren's co-authors include Fan Fan, Lee M. Ellis, Michael J. Gray, William E. Fisher, Nikolaos A. Dallas, Ling Xia, Somala Mohammed, Sherry J. Lim, Ray Somcio and Puja Gaur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

George Van Buren

51 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Van Buren United States 21 1.4k 968 583 416 321 52 2.2k
David Ho Hong Kong 21 1.1k 0.8× 1.0k 1.1× 643 1.1× 327 0.8× 154 0.5× 35 2.3k
Karl‐Heinz Thierauch Germany 19 908 0.6× 1.0k 1.1× 409 0.7× 265 0.6× 502 1.6× 33 2.5k
José A. López-Martín Spain 28 1.3k 0.9× 824 0.9× 352 0.6× 314 0.8× 601 1.9× 123 2.4k
Wing‐Kai Chan Taiwan 22 1.4k 1.0× 1.4k 1.4× 828 1.4× 307 0.7× 1.2k 3.7× 57 3.2k
Hongqing Xi China 24 543 0.4× 763 0.8× 561 1.0× 416 1.0× 631 2.0× 81 1.9k
Alain Thibault United States 24 694 0.5× 1.2k 1.2× 584 1.0× 293 0.7× 477 1.5× 49 2.5k
Hiroshi Sonoo Japan 26 1.3k 0.9× 820 0.8× 645 1.1× 238 0.6× 292 0.9× 123 2.3k
David Chu United States 27 1.1k 0.8× 1.1k 1.1× 428 0.7× 319 0.8× 674 2.1× 56 2.8k
Tracy Curley United States 24 1.1k 0.8× 1.7k 1.8× 395 0.7× 366 0.9× 1.3k 4.0× 51 3.3k
Zhen‐Zhou Shen China 31 1.5k 1.0× 1.2k 1.3× 1.1k 1.9× 185 0.4× 262 0.8× 54 2.9k

Countries citing papers authored by George Van Buren

Since Specialization
Citations

This map shows the geographic impact of George Van Buren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Van Buren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Van Buren more than expected).

Fields of papers citing papers by George Van Buren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Van Buren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Van Buren. The network helps show where George Van Buren may publish in the future.

Co-authorship network of co-authors of George Van Buren

This figure shows the co-authorship network connecting the top 25 collaborators of George Van Buren. A scholar is included among the top collaborators of George Van Buren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Van Buren. George Van Buren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Young‐Il, et al.. (2023). MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients. Cancers. 15(4). 998–998. 11 indexed citations
2.
Erstad, Derek J., Eric J. Silberfein, Cary Hsu, et al.. (2023). Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. Journal of the American College of Surgeons. 236(4). 861–870. 1 indexed citations
3.
Le, Duy T., Bryan M. Burt, George Van Buren, et al.. (2021). Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft. JCI Insight. 6(13). 12 indexed citations
4.
King, Mary Etta, Jialing Zhang, John Q. Lin, et al.. (2021). Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Proceedings of the National Academy of Sciences. 118(28). 50 indexed citations
5.
Ripley, R. Taylor, Shawn S. Groth, Eugene A. Choi, et al.. (2020). Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. The Annals of Thoracic Surgery. 112(5). 1568–1574. 5 indexed citations
6.
Poteet, Ethan, Dongliang Liu, Zhengdong Liang, et al.. (2019). Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib. PLoS ONE. 14(3). e0213294–e0213294. 9 indexed citations
7.
Villafañe-Ferriol, Nicole, George Van Buren, Amy L. McElhany, et al.. (2018). Sequential drain amylase to guide drain removal following pancreatectomy. HPB. 20(6). 514–520. 13 indexed citations
8.
Cao, Hop S. Tran, George Van Buren, Eric J. Silberfein, et al.. (2018). Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 165(2). 307–314. 14 indexed citations
9.
Villafañe-Ferriol, Nicole, Amy L. McElhany, Nader N. Massarweh, et al.. (2017). Sequential drain amylase to guide drain removal following pancreatectomy. HPB. 19. S59–S60. 1 indexed citations
10.
Villafañe-Ferriol, Nicole, Amy L. McElhany, Eric J. Silberfein, et al.. (2017). Evidence vs practice in early drain removal following pancreatectomy. HPB. 19. S35–S35. 1 indexed citations
11.
Villafañe-Ferriol, Nicole, Rohan Shah, Somala Mohammed, et al.. (2017). Evidence-Based Management of Drains Following Pancreatic Resection. Pancreas. 47(1). 12–17. 26 indexed citations
12.
Gilliland, Taylor, Nicole Villafañe-Ferriol, Kevin P. Shah, et al.. (2017). Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 9(3). 243–243. 145 indexed citations
13.
Buren, George Van, Ramesh K. Ramanathan, Alyssa M. Krasinskas, et al.. (2013). Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma. Annals of Surgical Oncology. 20(12). 3787–3793. 36 indexed citations
14.
Harvin, John A., George Van Buren, KuoJen Tsao, et al.. (2010). Hepatocellular Carcinoma Survival in Uninsured and Underinsured Patients. Journal of Surgical Research. 166(2). 189–193. 7 indexed citations
15.
Fan, Fan, Michael J. Gray, Nikolaos A. Dallas, et al.. (2008). Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Molecular Cancer Therapeutics. 7(9). 3064–3070. 24 indexed citations
16.
Gray, Michael J., Nikolaos A. Dallas, George Van Buren, et al.. (2008). Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene. 27(57). 7192–7200. 35 indexed citations
17.
Buren, George Van, Nikolaos A. Dallas, Ling Xia, et al.. (2008). Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver. JNCI Journal of the National Cancer Institute. 100(2). 109–120. 128 indexed citations
18.
Buren, George Van, Michael J. Gray, Nikolaos A. Dallas, et al.. (2007). A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) combined with bevacizumab inhibits the growth of colon cancer metastases in the liver: Differential effects mediated by tumor burden.. Molecular Cancer Therapeutics. 6. 2 indexed citations
19.
Dallas, Nikolaos A., Fan Fan, Michael J. Gray, et al.. (2007). Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. Cancer and Metastasis Reviews. 26(3-4). 433–41. 51 indexed citations
20.
Buren, George Van, et al.. (1983). Digital Radiography for Target Point Evaluation in Stereotactic Neurosurgery. Stereotactic and Functional Neurosurgery. 46(1-4). 206–210. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Ho Breakdown of academic impact, for papers by Karl‐Heinz Thierauch Breakdown of academic impact, for papers by José A. López-Martín Breakdown of academic impact, for papers by Wing‐Kai Chan Breakdown of academic impact, for papers by Hongqing Xi Breakdown of academic impact, for papers by Alain Thibault Breakdown of academic impact, for papers by Hiroshi Sonoo Breakdown of academic impact, for papers by David Chu Breakdown of academic impact, for papers by Tracy Curley Breakdown of academic impact, for papers by Zhen‐Zhou Shen
Rankless by CCL
2026